Actemra Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Phase 2 Study of Glofitamab as Monotherapy or in Combination With Polatuzumab Vedotin or Atezolizumab in Richter's Transformation
Conditions:   Chronic Lymphocytic Leukemia;   Richter's Transformation Interventions:   Drug: Glofitamab;   Drug: Obinutuzumab;   Drug: Polatuzumab Vedotin;   Drug: Atezolizumab;   Drug: Tocilizumab Sponsors:   Matthew S. Davids, MD;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

TocilizuMab discontinuAtion in GIant Cell Arteritis
Condition:   Giant Cell Arteritis Interventions:   Drug: Tocilizumab treatment;   Other: questionnaires;   Biological: Blood samples;   Procedure: 18FDG PET scan Sponsor:   Centre Hospitalier Universitaire Dijon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials